Ji Xiaoyu, Liang Weili, Yu Tiantian, Ding Changyuan, Lv Bin
Department of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Department of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Surgery. 2025 Apr;180:109028. doi: 10.1016/j.surg.2024.109028. Epub 2024 Dec 30.
This study aimed to evaluate the prognostic outcomes of thyroidectomy extent in unilateral TNM T1 or T2 papillary thyroid carcinoma with lateral lymph node metastasis.
Retrospective data were collected from unilateral papillary thyroid carcinoma patients with unilateral lymph node metastasis who underwent surgery at Qilu Hospital of Shandong University from 2011 to 2022. Patients were categorized into 2 groups based on the extent of the thyroidectomy (total thyroidectomy versus lobectomy). The primary endpoint was recurrence-free survival. The secondary endpoint was the incidence of complications. The Cox proportional hazards model was used to explore independent risk factors for structural recurrence.
A total of 372 patients with unilateral TNM T1 or T2 papillary thyroid carcinoma and unilateral lymph node metastasis were followed for a median of 55 months. Among them, 119 patients underwent lobectomy, whereas 253 patients underwent total thyroidectomy. During the follow-up period, 11 patients experienced structural recurrence. Kaplan-Meier analysis found no significant difference in recurrence-free survival between the groups (P > .05). However, the total thyroidectomy group had higher rates of both transient and permanent hypoparathyroidism, as well as transient recurrent laryngeal nerve injury (P < .05). Multivariate analysis identified minor extrathyroidal extension and lymph nodes ratio >0.49 as independent risk factors for structural recurrence, whereas the extent of thyroidectomy was not.
This study suggests that lobectomy does not impact the prognosis in unilateral TNM T1 and T2 papillary thyroid carcinoma patients with unilateral lymph node metastasis. Minor extrathyroidal extension and lymph nodes ratio >0.49 are identified as independent risk factors for structure recurrence, and patients exhibiting these risk factors should be subjected to vigilant postoperative monitoring.
本研究旨在评估单侧TNM T1或T2期伴侧方淋巴结转移的乳头状甲状腺癌患者甲状腺切除范围的预后结果。
收集2011年至2022年在山东大学齐鲁医院接受手术的单侧乳头状甲状腺癌伴单侧淋巴结转移患者的回顾性数据。根据甲状腺切除范围(全甲状腺切除术与叶切除术)将患者分为两组。主要终点是无复发生存期。次要终点是并发症的发生率。采用Cox比例风险模型探讨结构复发的独立危险因素。
共纳入372例单侧TNM T1或T2期乳头状甲状腺癌伴单侧淋巴结转移的患者,中位随访时间为55个月。其中,119例行叶切除术,253例行全甲状腺切除术。随访期间,11例患者出现结构复发。Kaplan-Meier分析发现两组间无复发生存期无显著差异(P>.05)。然而,全甲状腺切除术组的暂时性和永久性甲状旁腺功能减退以及暂时性喉返神经损伤发生率更高(P<.05)。多因素分析确定甲状腺外微小侵犯和淋巴结比例>0.49是结构复发的独立危险因素,而甲状腺切除范围不是。
本研究表明,叶切除术对单侧TNM T1和T2期伴单侧淋巴结转移的乳头状甲状腺癌患者的预后无影响。甲状腺外微小侵犯和淋巴结比例>0.49被确定为结构复发的独立危险因素,存在这些危险因素的患者应接受密切的术后监测。